Journal article

Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study

Julian H Elliott, James H McMahon, Christina C Chang, Sulggi A Lee, Wendy Hartogensis, Namandje Bumpus, Rada Savic, Janine Roney, Rebecca Hoh, Ajantha Solomon, Michael Piatak, Robert J Gorelick, Jeff Lifson, Peter Bacchetti, Steven G Deeks, Sharon R Lewin

The Lancet HIV | ELSEVIER INC | Published : 2015

University of Melbourne Researchers

Grants

Awarded by Foundation for AIDS Research (amfAR)


Awarded by Division of AIDS, National Institute of Allergy and Infectious Diseases, US National Institutes of Health (DARE: Delaney AIDS Research Enterprise)


Awarded by NIAID


Awarded by UCSF/Gladstone Institute of Virology & Immunology CFAR


Awarded by National Cancer Institute, National Institutes of Health


Awarded by UCSF Clinical and Translational Research Institute Clinical Research Center


Funding Acknowledgements

We acknowledge the participation and commitment of study participants, which made the study possible, and the contribution of the Alfred Hospital Infectious Diseases Clinical Research Unit, Melbourne, VIC, Australia, particularly Michelle Hagenauer. The study was supported by a research grant from the Foundation for AIDS Research (amfAR; 108465-52-RGRL) and additional support from the Division of AIDS, National Institute of Allergy and Infectious Diseases, US National Institutes of Health (DARE: Delaney AIDS Research Enterprise; U19AI096109). Additional support came from NIAID (K24 AI069994), the UCSF/Gladstone Institute of Virology & Immunology CFAR (P30 AI027763), the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E, and the UCSF Clinical and Translational Research Institute Clinical Research Center (UL1 RR024131). SRL is funded from an Australian National Health and Medical Research Council (NHMRC) Practitioner Fellowship. JHE and CCC are recipients of Australian NHMRC Early Career Fellowships. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organisations imply endorsement by the US Government.